3rd Quarter - Report — CRISPR THERAPEUTICS, INC. for CRISPR THERAPEUTICS, INC. (2021)

Firm

CRISPR THERAPEUTICS, INC.

Client

CRISPR THERAPEUTICS, INC.

Income

—

Expenses

$50,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Coverage & reimbursement for Cell and Gene Therapies

Lobbyist	Covered position, as disclosed
JOHN MARTIN	Head of Government Affairs

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Reimbursement for cell and gene therapies

Lobbyist	Covered position, as disclosed
JOHN MARTIN	Head of Government Affairs

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Coverage & reimbursement for Cell and Gene Therapies Sickle Cell Disease

Lobbyist	Covered position, as disclosed
JOHN MARTIN	—

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.